Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese [Phase 4]

View source ↗

Summary

This Phase 4 clinical study is evaluating tirzepatide's effects on reproductive function and metabolic health in overweight or obese women with polycystic ovary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mounjaro (tirzepatide) (tirzepatide)

Snippet

Sponsor: University of Bonn | Conditions: Polycystic Ovary Syndrome (PCOS), Obesity & Overweight | Phase 4 | Status: RECRUITING